Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/28/2025

Management of Methamphetamine-Associated Myocardial Infarction

Initial Assessment and Treatment

  • The American Heart Association recommends treating methamphetamine-induced myocardial infarction identically to cocaine-induced MI, prioritizing nitrates and calcium channel blockers for vasospasm, avoiding beta-blockers, obtaining immediate ECG and troponins, and proceeding with reperfusion therapy (PCI preferred over fibrinolysis) if ST-elevation is present 1, 2
  • Obtain 12-lead ECG immediately to identify ST-segment elevation ≥1 mm in contiguous leads or new left bundle branch block, as recommended by the American College of Cardiology 1, 3
  • Administer aspirin 160-325 mg orally immediately unless contraindicated, as suggested by the American Heart Association 3
  • Draw troponin at presentation and plan repeat measurement at 6-hour intervals, as troponin is more specific than CK-MB for myocardial injury in stimulant users who may have rhabdomyolysis, according to the American College of Cardiology 1, 2

Pharmacologic Management of Vasospasm

  • Administer sublingual nitroglycerin (up to 3 doses, 5 minutes apart) unless systolic BP <90 mmHg, heart rate <50 or >100 bpm, as recommended by the American Heart Association 1, 2, 3
  • Add calcium channel blockers (verapamil preferred) as these reverse methamphetamine-induced coronary vasoconstriction and hypertension, according to the American College of Cardiology 1, 2
  • Continue intravenous nitroglycerin infusion for ongoing chest pain or ST-segment changes, as suggested by the American Heart Association 1, 2

Reperfusion Strategy

  • Primary PCI is the preferred reperfusion method if available within 90 minutes of first medical contact, as recommended by the American College of Cardiology 1, 3
  • Use bare-metal stents rather than drug-eluting stents, as substance abusers are unreliable with prolonged dual-antiplatelet therapy adherence, creating substantial risk of in-stent thrombosis, according to the American Heart Association 1, 2
  • Administer P2Y12 inhibitor (clopidogrel) in addition to aspirin for dual-antiplatelet therapy, as suggested by the American College of Cardiology 1, 3

Special Diagnostic Considerations

  • Prioritize troponin I or troponin T over CK-MB, as methamphetamine use causes increased motor activity, skeletal muscle injury, and rhabdomyolysis that elevate CK and CK-MB without myocardial infarction, according to the American Heart Association 1, 2
  • Serial troponin measurements are essential; do not rely on single measurement, as recommended by the American College of Cardiology 1, 2

Critical Pitfalls to Avoid

  • Do not wait for troponin results before initiating reperfusion therapy in ST-elevation MI—ECG findings alone warrant immediate treatment, as suggested by the American Heart Association 1, 3
  • Do not administer beta-blockers for hypertension or tachycardia, as this worsens coronary vasoconstriction, according to the American College of Cardiology 1, 2
  • Do not use drug-eluting stents due to high risk of non-adherence to prolonged dual-antiplatelet therapy, as recommended by the American Heart Association 1, 2